Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-11-30 | 2023-12-07 | 212001 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-01-19 | 2023-02-09 | 181588 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-04-27 | 2023-11-21 | 190680 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2020-07-23 | 2020-09-03 | 120917 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2020-09-11 | 2021-01-14 | 124098 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2020-10-15 | 2021-03-04 | 126513 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-06-16 | 2023-07-07 | 195180 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-11-30 | 2024-01-08 | 211998 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-12-14 | 2024-03-21 | 213374 |
| ACT METFORMIN | 850MG | TABLET | Resolved | 2020-10-01 | 2020-10-22 | 125455 |
| ACT METFORMIN | 500MG | TABLET | Resolved | 2020-06-25 | 2020-08-27 | 118912 |
| ACT METFORMIN | 500MG | TABLET | Resolved | 2020-04-03 | 2020-04-23 | 110806 |
| ACT METFORMIN | 850MG | TABLET | Resolved | 2020-01-17 | 2020-10-22 | 103584 |
| ACT METFORMIN | 500MG | TABLET | Resolved | 2020-04-03 | 2020-05-14 | 110803 |
| ACT METFORMIN | 500MG | TABLET | Resolved | 2020-04-03 | 2020-06-04 | 110800 |
| ACT METFORMIN | 850MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110649 |
| ACT METFORMIN | 850MG | TABLET | Resolved | 2023-01-19 | 2023-04-28 | 181594 |
| ACT METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-28 | 2024-05-09 | 223862 |
| ACT METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-05-16 | 2024-09-19 | 228143 |
| ACT METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-11-01 | 2024-02-13 | 65990 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 |